Skip to main content
Log in

The prevalence of positive thyroid autoantibodies in patients with subacute thyroiditis: a systematic review and meta-analysis

  • Review
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Purpose:

Subacute thyroiditis (SAT) is a transient inflammatory disorder of the thyroid gland with a possible viral etiology. We conducted this study to estimate the pooled prevalence of thyroid autoantibodies in SAT patients. This question arose due to the varying reports on the positivity rates of thyroid autoantibodies among SAT patients.

Methods:

We searched PubMed, Embase, Scopus, and Web of Science from their inception until March 25th, 2023. Observational studies reporting the positivity rate of thyroid autoantibodies for more than ten patients were included. We used the Joanna Briggs Institute’s (JBI) critical appraisal checklist to assess the quality of the included studies. Pooled prevalence estimates with 95% confidence intervals were calculated using the random effects model. Subgroup analyses were performed to find sources of heterogeneity.

Results:

Out of 1373 identified records, 32 studies involving 2348 SAT patients were included in our study. Thyroglobulin antibody (TgAb) and thyroid peroxidase antibody (TPOAb) were positive in 22.8% and 12.2% of patients, respectively. The Study design, mean erythrocyte sedimentation rate and mean thyroid-stimulating hormone of patients were identified as sources of heterogeneity. As our secondary objectives, we found a recurrence rate of 14.7% and permanent hypothyroidism in 11.6% of patients.

Conclusion:

The results of our study revealed a low TPOAb positivity rate in SAT patients, consistent with its non-autoimmune etiology. The TgAb positivity rate in SAT patients was higher than that of the general population, possibly explained by the transient release of thyroglobulin into the bloodstream during the thyrotoxic phase, leading to subsequent TgAb production. Furthermore, our findings demonstrate a notable recurrence rate and permanent hypothyroidism among SAT patients, highlighting the importance of ongoing follow-up care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. M. Popescu, A. Ghemigian, C.M. Vasile, A. Costache, M. Carsote, A.E. Ghenea, The new entity of subacute thyroiditis amid the COVID-19 pandemic: from infection to vaccine. Diagnostics (Basel) 12, 960 (2022). https://doi.org/10.3390/diagnostics12040960

    Article  CAS  PubMed  Google Scholar 

  2. N. Erdem, M. Erdogan, M. Ozbek, M. Karadeniz, S. Cetinkalp, A.G. Ozgen, F. Saygili, C. Yilmaz, M. Tuzun, T. Kabalak, Demographic and clinical features of patients with subacute thyroiditis: results of 169 patients from a single university center in Turkey. J. Endocrinol. Invest. 30, 546–550 (2007). https://doi.org/10.1007/BF03346347

    Article  CAS  PubMed  Google Scholar 

  3. V. Fatourechi, J.P. Aniszewski, G.Z.E. Fatourechi, E.J. Atkinson, S.J. Jacobsen, Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minnesota, study. J. Clin. Endocrinol. Metab. 88, 2100–2105 (2003). https://doi.org/10.1210/jc.2002-021799

    Article  CAS  PubMed  Google Scholar 

  4. P. He, H. Yang, Q. Lai, Y. Kuang, Z. Huang, X. Liang, H. Huang, Y. Qin, Z. Luo, The diagnostic value of blood cell-derived indexes in subacute thyroiditis patients with thyrotoxicosis: a retrospective study. Ann. Transl. Med. 10, 322 (2022). https://doi.org/10.21037/atm-22-719

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. J. Görges, J. Ulrich, C. Keck, D. Müller-Wieland, S. Diederich, O.E. Janssen, Long-term outcome of subacute thyroiditis. Exp. Clin. Endocrinol Diabetes 128, 703–708 (2020). https://doi.org/10.1055/a-0998-8035

    Article  CAS  PubMed  Google Scholar 

  6. J. Zhang, G. Ding, J. Li, X. Li, L. Ding, X. Li, S. Yang, F. Tang, Risk factors for subacute thyroiditis recurrence: A systematic review and meta-analysis of cohort studies. Front Endocrinol (Lausanne) 12, 783439 (2021). https://doi.org/10.3389/fendo.2021.783439

    Article  PubMed  Google Scholar 

  7. S.N. Dwivedi, T. Kalaria, H. Buch, Thyroid autoantibodies. J. Clin. Pathol 76, 19–28 (2023). https://doi.org/10.1136/jcp-2022-208290

    Article  CAS  PubMed  Google Scholar 

  8. J. Klubo-Gwiezdzinska, L. Wartofsky, Hashimoto thyroiditis: an evidence-based guide to etiology, diagnosis and treatment. Pol. Arch. Intern. Med. 132, 16222 (2022). https://doi.org/10.20452/pamw.16222

    Article  PubMed  PubMed Central  Google Scholar 

  9. F. Bogazzi, L. Bartalena, S. Brogioni, A. Burelli, L. Manetti, M.L. Tanda, M. Gasperi, E. Martino, Thyroid vascularity and blood flow are not dependent on serum thyroid hormone levels: studies in vivo by color flow doppler sonography. Eur. J. Endocrinol 140, 452–456 (1999). https://doi.org/10.1530/eje.0.1400452

    Article  CAS  PubMed  Google Scholar 

  10. M.E. Sencar, M. Calapkulu, D. Sakiz, S. Hepsen, A. Kus, P. Akhanli, I.O. Unsal, M. Kizilgul, B. Ucan, M. Ozbek, E. Cakal, An evaluation of the results of the steroid and non-steroidal anti-inflammatory drug treatments in subacute thyroiditis in relation to persistent hypothyroidism and recurrence. Sci. Rep. 9, 16899 (2019). https://doi.org/10.1038/s41598-019-53475-w

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. N. Omori, K. Omori, K. Takano, Association of the ultrasonographic findings of subacute thyroiditis with thyroid pain and laboratory findings. Endocr. J. 55, 583–588 (2008). https://doi.org/10.1507/endocrj.k07e-163

    Article  PubMed  Google Scholar 

  12. J. Sato, T. Uchida, K. Komiya, H. Goto, K. Takeno, R. Suzuki, A. Honda, M. Himuro, H. Watada, Comparison of the therapeutic effects of prednisolone and nonsteroidal anti-inflammatory drugs in patients with subacute thyroiditis. Endocrine 55, 209–214 (2017). https://doi.org/10.1007/s12020-016-1122-3

    Article  CAS  PubMed  Google Scholar 

  13. E. Nishihara, N. Amino, T. Kudo, K. Kohsaka, M. Ito, S. Fukata, M. Nishikawa, H. Nakamura, A. Miyauchi, Moderate frequency of anti-thyroglobulin antibodies in the early phase of subacute thyroiditis. Eur. Thyroid. J. 8, 268–272 (2019). https://doi.org/10.1159/000501033

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Ç.T. Bahadir, M. Yilmaz, E. Kiliçkan, Factors affecting recurrence in subacute granulomatous thyroiditis. Arch. Endocrinol. Metab. 66, 286–294 (2022). https://doi.org/10.20945/2359-3997000000473

    Article  PubMed  PubMed Central  Google Scholar 

  15. D. Fadime, Cut off value of technetium uptake in the differential diagnosis of Graves, disease and subacute thyroiditis. Asia Ocean J. Nucl. Med. Biol. 8, 54–57 (2020). https://doi.org/10.22038/aojnmb.2019.14241

    Article  PubMed  PubMed Central  Google Scholar 

  16. M.A. Hasanat, M.A. Rumi, M.N. Alam, K.N. Hasan, M. Salimullah, M.A. Salam, M. Fariduddin, H. Mahtab, A.K. Khan, Status of antithyroid antibodies in Bangladesh. Postgrad. Med. J. 76, 345–349 (2000). https://doi.org/10.1136/pmj.76.896.345

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. M.J. Page, J.E. McKenzie, P.M. Bossuyt, I. Boutron, T.C. Hoffmann, C.D. Mulrow, L. Shamseer, J.M. Tetzlaff, E.A. Akl, S.E. Brennan, R. Chou, J. Glanville, J.M. Grimshaw, A. Hróbjartsson, M.M. Lalu, T. Li, E.W. Loder, E. Mayo-Wilson, S. McDonald, L.A. McGuinness, L.A. Stewart, J. Thomas, A.C. Tricco, V.A. Welch, P. Whiting, D. Moher, The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372, n71 (2021). https://doi.org/10.1136/bmj.n71

    Article  PubMed  PubMed Central  Google Scholar 

  18. Z. Munn, S. Moola, K. Lisy, D. Riitano, C. Tufanaru, Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int. J. Evid. Based Healthc 13, 147–153 (2015). https://doi.org/10.1097/XEB.0000000000000054

    Article  PubMed  Google Scholar 

  19. C.B. Begg, M. Mazumdar, Operating characteristics of a rank correlation test for publication bias. Biometrics 50, 1088–1101 (1994)

    Article  CAS  PubMed  Google Scholar 

  20. M. Egger, G. Davey Smith, M. Schneider, C. Minder, Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629–634 (1997). https://doi.org/10.1136/bmj.315.7109.629

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. S. Duval, R. Tweedie, Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56, 455–463 (2000). https://doi.org/10.1111/j.0006-341x.2000.00455.x

    Article  CAS  PubMed  Google Scholar 

  22. J.G. Hollowell, N.W. Staehling, W.D. Flanders, W.H. Hannon, E.W. Gunter, C.A. Spencer, L.E. Braverman, Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol Metab. 87, 489–499 (2002). https://doi.org/10.1210/jcem.87.2.8182

    Article  CAS  PubMed  Google Scholar 

  23. A. Amouzegar, S. Gharibzadeh, E. Kazemian, L. Mehran, M. Tohidi, F. Azizi, The prevalence, incidence and natural course of positive antithyroperoxidase antibodies in a population-based study: Tehran Thyroid Study. PLoS One 12, e0169283 (2017). https://doi.org/10.1371/journal.pone.0169283

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. M.P. Baruah, B. Bhattacharya, U.M. Baruah, C-Reactive Protein Level can be a Better Indicator than Erythrocyte Sedimentation Rate in Assessing the Severity of Inflammation and Guiding Glucocorticoid Therapy in Subacute Thyroiditis. Indian J. Endocrinol Metab. 26, 328–333 (2022). https://doi.org/10.4103/ijem.ijem_229_22

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. A. Brancatella, N. Viola, G. Rutigliano, D. Sgrò, F. Santini, F. Latrofa, Subacute Thyroiditis during the SARS-CoV-2 pandemic. J. Endocr. Soc. 5, bvab130 (2021). https://doi.org/10.1210/jendso/bvab130

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. K. Luotola, P. Mantula, J. Salmi, A.M. Haapala, P. Laippala, M. Hurme, Allele 2 of interleukin-1 receptor antagonist gene increases the risk of thyroid peroxidase antibodies in subacute thyroiditis. APMIS 109, 454–460 (2001). https://doi.org/10.1034/j.1600-0463.2001.090608.x

    Article  CAS  PubMed  Google Scholar 

  27. C.A. Spencer, M. Takeuchi, M. Kazarosyan, C.C. Wang, R.B. Guttler, P.A. Singer, S. Fatemi, J.S. LoPresti, J.T. Nicoloff, Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. J. Clin. Endocrinol. Metab. 83, 1121–1127 (1998). https://doi.org/10.1210/jcem.83.4.4683

    Article  CAS  PubMed  Google Scholar 

  28. Y. Li, D. Teng, Z. Shan, X. Teng, H. Guan, X. Yu, C. Fan, W. Chong, F. Yang, H. Dai, X. Gu, Y. Yu, J. Mao, D. Zhao, J. Li, Y. Chen, R. Yang, C. Li, W. Teng, Antithyroperoxidase and antithyroglobulin antibodies in a five-year follow-up survey of populations with different iodine intakes. J. Clin. Endocrinol. Metab. 93, 1751–1757 (2008). https://doi.org/10.1210/jc.2007-2368

    Article  CAS  PubMed  Google Scholar 

  29. D. Ricci, A. Brancatella, M. Marinò, M. Rotondi, L. Chiovato, P. Vitti, F. Latrofa, The detection of serum IgMs to thyroglobulin in subacute thyroiditis suggests a protective role of IgMs in thyroid autoimmunity. J. Clin. Endocrinol Metab. 105, dgaa038 (2020). https://doi.org/10.1210/clinem/dgaa038

    Article  PubMed  Google Scholar 

  30. R. Volpé, V.V. Row, C. Ezrin, Circulating viral and thyroid antibodies in subacute thyroiditis. J. Clin. Endocrinol Metab. 27, 1275–1284 (1967). https://doi.org/10.1210/jcem-27-9-1275

    Article  PubMed  Google Scholar 

  31. A. Kotwal, M. Stan, Thyrotropin receptor antibodies-an overview. Ophthalmic Plast Reconstr. Surg. 34, S20–S27 (2018). https://doi.org/10.1097/IOP.0000000000001052

    Article  PubMed  Google Scholar 

  32. G. Barbesino, Y. Tomer, Clinical review: Clinical utility of TSH receptor antibodies. J. Clin. Endocrinol Metab. 98, 2247–2255 (2013). https://doi.org/10.1210/jc.2012-4309

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. T. Diana, K.A. Ponto, G.J. Kahaly, Thyrotropin receptor antibodies and Graves’ orbitopathy. J. Endocrinol Invest. 44, 703–712 (2021). https://doi.org/10.1007/s40618-020-01380-9

    Article  CAS  PubMed  Google Scholar 

  34. M. Stasiak, B. Tymoniuk, B. Stasiak, A. Lewiński, The risk of recurrence of subacute thyroiditis is HLA-dependent. Int. J. Mol. Sci. 20, 1089 (2019). https://doi.org/10.3390/ijms20051089

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. D.S. Ross, H.B. Burch, D.S. Cooper, M.C. Greenlee, P. Laurberg, A.L. Maia, S.A. Rivkees, M. Samuels, J.A. Sosa, M.N. Stan, M.A. Walter, 2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 26, 1343–1421 (2016). https://doi.org/10.1089/thy.2016.0229

    Article  PubMed  Google Scholar 

  36. A. Saklamaz, Is there a drug effect on the development of permanent hypothyroidism in subacute thyroiditis? Acta Endocrinol (Buchar) 13, 119–123 (2017). https://doi.org/10.4183/aeb.2017.119

    Article  CAS  PubMed  Google Scholar 

  37. M. Ziaka, A. Exadaktylos, Insights into SARS-CoV-2-associated subacute thyroiditis: from infection to vaccine. Virol J. 20, 132 (2023). https://doi.org/10.1186/s12985-023-02103-1

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. M. Rotondi, F. Coperchini, G. Ricci, M. Denegri, L. Croce, S.T. Ngnitejeu, L. Villani, F. Magri, F. Latrofa, L. Chiovato, Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis. J. Endocrinol Invest 44, 1085–1090 (2021). https://doi.org/10.1007/s40618-020-01436-w

    Article  CAS  PubMed  Google Scholar 

  39. M. Stasiak, A. Lewiński, New aspects in the pathogenesis and management of subacute thyroiditis. Rev. Endocr. Metab. Disord. 22, 1027–1039 (2021). https://doi.org/10.1007/s11154-021-09648-y

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. N. Viola, A. Brancatella, D. Sgrò, F. Santini, F. Latrofa, Clinical, biochemical features and functional outcome of patients with SARS-CoV-2-related subacute thyroiditis: a review. Endocrine 79, 448–454 (2023). https://doi.org/10.1007/s12020-022-03247-w

    Article  CAS  PubMed  Google Scholar 

  41. E. Meftah, R. Rahmati, F. Zari Meidani, S. Khodadadi, K. Chitzan-Zadeh, F. Esfahanian, S. Afshar, Subacute thyroiditis following COVID-19: A systematic review. Front Endocrinol (Lausanne) 14, 1126637 (2023). https://doi.org/10.3389/fendo.2023.1126637

    Article  PubMed  Google Scholar 

  42. N. Araki, M. Iida, N. Amino, S. Morita, A. Ide, E. Nishihara, M. Ito, J. Saito, T. Nishikawa, K. Katsuragi, A. Miyauchi, Rapid bioassay for detection of thyroid-stimulating antibodies using cyclic adenosine monophosphate-gated calcium channel and aequorin. Eur. Thyroid J. 4, 14–19 (2015). https://doi.org/10.1159/000371740

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. P.G. Espinoza, C.L. Guendelman, L.N. Quevedo Limón, R.J. Fernández, A comparison between two imaging techniques for the diagnosis of subacute thyroiditis (de Quervain thyroiditis): brief communication. Clin. Nucl. Med. 35, 862–864 (2010). https://doi.org/10.1097/RLU.0b013e3181f49adc

    Article  PubMed  Google Scholar 

  44. S. Hepsen, P. Akhanli, M.E. Sencar, H. Duger, D. Sakiz, M. Kizilgul, I. Ozturk Unsal, B. Ucan, M. Ozbek, E. Cakal, The evaluation of low- and high-dose steroid treatments in subacute thyroiditis: A retrospective observational study. Endocr Pract 27, 594–600 (2021). https://doi.org/10.1016/j.eprac.2020.11.009

    Article  PubMed  Google Scholar 

  45. K. Kamijo, K. Ishikawa, M. Tanaka, Clinical evaluation of 3rd generation assay for thyrotropin receptor antibodies: the M22-biotin-based ELISA initiated by Smith. Endocr. J. 52, 525–529 (2005). https://doi.org/10.1507/endocrj.52.525

    Article  CAS  PubMed  Google Scholar 

  46. K. Kamijo, H. Murayama, T. Uzu, K. Togashi, G.J. Kahaly, A novel bioreporter assay for thyrotropin receptor antibodies using a chimeric thyrotropin receptor (mc4) is more useful in differentiation of Graves’ disease from painless thyroiditis than conventional thyrotropin-stimulating antibody assay using porcine thyroid cells. Thyroid 20, 851–856 (2010). https://doi.org/10.1089/thy.2010.0059

    Article  CAS  PubMed  Google Scholar 

  47. S.H. Khan, A. Mahajan, B.A. Laway, R. Rasool, T.A. Rather, Technetium-99m Thyroid Scintigraphy and Human Leukocyte Antigen – B35 in Sub-Acute Thyroiditis. Indian J. Nucl. Med. 33, 306–311 (2018). https://doi.org/10.4103/ijnm.IJNM_74_18

    Article  PubMed  PubMed Central  Google Scholar 

  48. J. Kim, H.-S. Baek, J. Ha, M.K. Kim, H.-S. Kwon, K.-H. Song, D.-J. Lim, K.-H. Baek, Differential diagnosis of thyrotoxicosis by machine learning models with laboratory findings. Diagnostics (Basel) 12, 1468 (2022). https://doi.org/10.3390/diagnostics12061468

    Article  CAS  PubMed  Google Scholar 

  49. J.I. Lee, H.W. Jang, S.K. Kim, J.Y. Choi, J.Y. Kim, K.Y. Hur, J.H. Kim, Y.-K. Min, J.H. Chung, S.W. Kim, Diagnostic value of a chimeric TSH receptor (Mc4)-based bioassay for Graves’ disease. Korean J. Intern Med. 26, 179–186 (2011). https://doi.org/10.3904/kjim.2011.26.2.179

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. J. Yoshimura Noh, N. Miyazaki, K. Ito, K. Takeda, S. Hiramatsu, S. Morita, A. Miyauchi, T. Murakami, K. Inomata, S. Noguchi, T. Satoh, N. Amino, Evaluation of a new rapid and fully automated electrochemiluminescence immunoassay for thyrotropin receptor autoantibodies. Thyroid 18, 1157–1164 (2008). https://doi.org/10.1089/thy.2008.0119

    Article  CAS  PubMed  Google Scholar 

  51. H. Ota, N. Amino, S. Morita, K. Kobayashi, S. Kubota, S. Fukata, N. Kamiyama, A. Miyauchi, Quantitative measurement of thyroid blood flow for differentiation of painless thyroiditis from Graves’ disease. Clin. Endocrinol (Oxf) 67, 41–45 (2007). https://doi.org/10.1111/j.1365-2265.2007.02832.x

    Article  PubMed  Google Scholar 

  52. M. Schott, D. Hermsen, M. Broecker-Preuss, M. Casati, J.C. Mas, A. Eckstein, D. Gassner, R. Golla, C. Graeber, J. van Helden, K. Inomata, J. Jarausch, J. Kratzsch, N. Miyazaki, M.A.N. Moreno, T. Murakami, H.J. Roth, W. Stock, J.Y. Noh, W.A. Scherbaum, K. Mann, Clinical value of the first automated TSH receptor autoantibody assay for the diagnosis of Graves’ disease (GD): an international multicentre trial. Clin. Endocrinol (Oxf) 71, 566–573 (2009). https://doi.org/10.1111/j.1365-2265.2008.03512.x

    Article  CAS  PubMed  Google Scholar 

  53. M.E. Sencar, M. Çalapkulu, D. Sakiz, S. Hepsen, P. Akhanli, İ. Öztürk Ünsal, E. Çakal, Frequency of thyroid antibodies at the diagnosis of subacute thyroiditis. Turk. J. Endocrinol Metab. 24, 144–148 (2020). https://doi.org/10.25179/tjem.2020-74287

    Article  Google Scholar 

  54. M. Stasiak, R. Michalak, B. Stasiak, A. Lewinski, Clinical characteristics of subacute thyroiditis is different than it used to be - current state based on 15 years own material. Neuro Endocrinol Lett. 39, 489–495 (2019)

    PubMed  Google Scholar 

  55. N. Takasu, K. Kamijo, Y. Sato, H. Yoshimura, A. Nagata, Y. Ochi, Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves’ disease. Clin. Exp. Pharmacol Physiol. 31, 314–319 (2004). https://doi.org/10.1111/j.1440-1681.2004.03991.x

    Article  CAS  PubMed  Google Scholar 

  56. J.R. Wall, C.R. Strakosch, P. Bandy, R. Bayly, Nature of thyrotropin displacement activity in subacute thyroiditis. J. Clin. Endocrinol Metab. 54, 349–353 (1982). https://doi.org/10.1210/jcem-54-2-349

    Article  CAS  PubMed  Google Scholar 

  57. Y. Thewjitcharoen, K. Sirinate, B. Siriwan, N. Soontaree, H. Thep, Clinical features and outcomes of subacute thyroiditis in Thai patients. JAFES 30, 125–128 (2015). https://doi.org/10.15605/jafes.030.02.03

    Article  Google Scholar 

  58. Y. Zhou, M. Zhou, Y. Qi, W. Wang, X. Chen, S. Wang, The prognostic value of thyroid-stimulating immunoglobulin in the management of Graves’ disease. Ther. Adv. Endocrinol Metab. 12, 20420188211044943 (2021). https://doi.org/10.1177/20420188211044943

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author contributions

A.S.: search strategy development, study selection, data extraction, quality assessment, drafting the manuscript, M.F.: search strategy development, quality assessment, statistical analysis, manuscript revision, S.M.-T.: data extraction, manuscript revision, A.Y.: study selection, manuscript revision, M.H.: study conceptualization, resolving the disagreements during the study selection, data extraction, and quality assessment processes, manuscript revision, All authors read and approved the final version of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maryam Heidarpour.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shekarian, A., Fakhrolmobasheri, M., Mazaheri-Tehrani, S. et al. The prevalence of positive thyroid autoantibodies in patients with subacute thyroiditis: a systematic review and meta-analysis. Endocrine 84, 29–41 (2024). https://doi.org/10.1007/s12020-023-03655-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-023-03655-6

Keywords

Navigation